Now showing items 1-7 of 7

  • Clinical trials in restless legs syndrome - Recommendations of the European RLS study group (EURLSSG) 

    Trenkwalder, C.; Kohnen, R.; Allen, R. P.; Benes, H.; Ferini-Strambi, L.; Garcia-Borreguero, D.; Hadjigeorgiou, G. M.; Happe, S.; Hogl, B.; Hornyak, M.; Klein, C.; Nass, A.; Montagna, P.; Oertel, W. H.; O'Keeffe, S.; Paulus, W.; Poewe, W.; Provini, F.; Pramstaller, P. P.; Sieminski, M.; Sonka, K.; Stiasny-Kolster, K.; de Weerd, A.; Wetter, T. C.; Winkelmann, J.; Zucconi, M. (2007)
    The European Restless Leas Syndrome (RLS) Study Group (EURLSSG) is an association of European RLS experts who are actively involved in RLS research. A major aim of the Study Group is the development and continuous improvement ...
  • Efficacy of rifampicin in the treatment of experimental acute canine monocytic ehrlichiosis 

    Theodorou, K.; Mylonakis, M. E.; Siarkou, V. I.; Leontides, L.; Koutinas, A. F.; Koutinas, C. K.; Kritsepi-Konstantinou, M.; Batzias, G.; Flouraki, E.; Eyal, O.; Kontos, V.; Harrus, S. (2013)
    To assess the efficacy of rifampicin in achieving clinical and haematological recovery and clearing infection in dogs with experimentally induced acute monocytic ehrlichiosis. Five Ehrlichia canis-infected Beagle dogs were ...
  • Investigational therapies targeted to the treatment of benign prostatic hyperplasia 

    Gravas, S.; de la Rosette, Jjmch (2013)
    Introduction: The desired goals of treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) include sustained, clinically significant improvement in symptoms and quality of life and/or ...
  • Patient-specific internal radionuclide dosimetry 

    Tsougos, I.; Loudos, G.; Georgoulias, P.; Theodorou, K.; Kappas, C. (2010)
    The development of patient-specific treatment planning systems is of outmost importance in the development of radionuclide dosimetry, taking into account that quantitative three-dimensional nuclear medical imaging can be ...
  • Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis 

    Kabacam, G.; Dalekos, G. N.; Cakaloglu, Y.; Zachou, K.; Bock, T.; Erhardt, A.; Zeuzem, S.; Tabak, F.; Yalcin, K.; Bozdayi, A. M.; Dienes, H. P.; Bozkaya, H.; Manns, M.; Wedemeyer, H.; Yurdaydin, C. (2012)
    Background/aims: The safety and efficacy of interferons in advanced delta hepatitis have not been explored. The aim of this subanalysis of a multi-center clinical trial was to compare the efficacy and safety of 48 weeks ...
  • Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience 

    Tillmann, H. L.; Hadem, J.; Leifeld, L.; Zachou, K.; Canbay, A.; Eisenbach, C.; Graziadei, I.; Encke, J.; Schmidt, H.; Vogel, W.; Schneider, A.; Spengler, U.; Gerken, G.; Dalekos, G. N.; Wedemeyer, H.; Manns, M. P. (2006)
    Acute hepatitis B progresses to liver failure with the need of liver transplantation in about 1% of cases. We treated patients with severe acute or fulminant hepatitis B with lamivudine in an attempt to prevent hepatitis ...
  • Software upgrading in a CT scanner - Influence on quantitative CT 

    KalefEzra, J. A.; Karantanas, A. H. (1996)
    Purpose: In an attempt to improve field uniformity and CT number stability, the software in a CT scanner was replaced with a new version. The purpose of the present study was to investigate the influence of the software ...